JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Farah, A.
Right arrow Articles by Tuttle, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Farah, A.
Right arrow Articles by Tuttle, R.
Journal of Pharmacology And Experimental Therapeutics, Vol. 129, Issue 1, 49-55, 1960
Copyright © 1960 by American Society for Pharmacology and Experimental Therapeutics


STUDIES ON THE PHARMACOLOGY OF GLUCAGON

A. Farah 1 and R. Tuttle 1

1 Department of Pharmacology, State University of New York, Upstate Medical Center, Syracuse, New York

Crystalline glucagon preparations produced a positive chronotropic and inotropic effect on isolated hearts of the dog, cat, guinea pig and rat. No such effects could be demonstrated in isolated rabbit hearts or atria or on hearts of the intact anesthetized dog.

These effects of glucagon are not prevented by pretreating the dog with reserpine but can be abolished or reduced by the adrenergic blocking agent dichloroisoproterenol. Glucagon produced a relaxation and inhibited of spontaneous activity in the isolated rabbit and cat intestine which was similar to that produced by epinephrine and some amorphous insulin preparations.

The above observations make it likely that glucagon has, besides its epinephrine-like effects on the liver, epinephrine-like effects in the isolated heart and intestine of some species. The quantitative data presented indicate that the biological effects observed here are due to the same substance, presumably glucagon, and are most probably not caused by an impurity which contaminates crystalline glucagon.

Submitted on October 15, 1959




This article has been cited by other articles:


Home page
J. Exp. Biol.Home page
T. Uesaka, K. Yano, S. Sugimoto, and M. Ando
Glucagon-like peptide isolated from the eel intestine: effects on atrial beating
J. Exp. Biol., January 9, 2001; 204(17): 3019 - 3026.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. Sauvadet, T. Rohn, F. Pecker, and C. Pavoine
Synergistic Actions of Glucagon and Miniglucagon on Ca2+ Mobilization in Cardiac Cells
Circ. Res., January 1, 1996; 78(1): 102 - 109.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1960 by the American Society for Pharmacology and Experimental Therapeutics.